Source: Interfolio F180
![](http://www.scripps.edu/_faculty/headshots/300x300_mansun_law.jpg)
Mansun Law
Education
Ph.D. (Virology), University of Oxford, 2001M.Phil. (Molecular Biology), The University of Hong Kong, 1998
B.S. (Biotechnology), The University of Hong Kong, 1995
Selected Publications
Salas, Jordan H.; Urbanowicz, Richard A.; Guest, Johnathan D.; Frumento, Nicole; Figueroa, Alexis; Clark, Kaitlyn E.; Keck, Zhenyong; Cowton, Vanessa M.; Cole, Sarah J.; Patel, Arvind H.; Fuerst, Thomas R.; Drummer, Heidi E.; Major, Marian; Tarr, Alexander W.; Ball, Jonathan K.; Law, Mansun; Pierce, Brian G.; Foung, Steven K.; Bailey, Justin R. An antigenically diverse, representative panel of envelope glycoproteins for HCV vaccine development. Gastroenterology 2021, 562-574.
Yechezkel, Itai; Tzarum, Netanel; Law, Mansun From Structural Studies to HCV Vaccine Design. Viruses 2021.
Chen, Fang; Tzarum, Netanel; Lin, Xiaohe; Giang, Erick; Velazquez-moctezuma, Rodrigo; Augestad, Elias H.; Nagy, Kenna; He, Linling; Hernandez, Mayda; Fouch, Mallorie E.; Grinyo, Ariadna; Chavez, Deborah; Doranz, Benjamin J.; Prentoe, Jannick; Stanfield, Robyn L.; Lanford, Robert E.; Bukh, Jens; Wilson, Ian A.; Zhu, Jiang; Law, Mansun Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins. Immunity 2021, 781-796.e4.
Olson, Margaret E.; Law, Mansun; Janda, Kim D.; Giang, Erick; Belz, Tyson F. Evaluation of a Series of Lipidated Tucaresol Adjuvants in a Hepatitis C Virus Vaccine Model. ACS Medicinal Chemistry Letters 2020, 2428-2432.
Chen, Fang; Lairson, Luke L.; Law, Mansun Into the Unknown: A Chemical Biology Approach Provides Mechanistic Insight into HCV Entry. Cell Chemical Biology 2020, 27, 767-769.
[View]
Tzarum, N.; Giang, E.; Kadam, R. U.; Chen, Fang; Nagy, K.; Augestad, E. H.; Velazquez-Moctezuma, R.; Keck, Z. Y.; Hua, Y. Z.; Stanfield, Robyn L.; Dreux, M.; Prentoe, J.; Foung, S. K.; Bukh, J.; Wilson, Ian A.; Law, Mansun An alternate conformation of HCV E2 neutralizing face as an additional vaccine target. Science Advances 2020, 6.
[View]